ISPOR BUDGET IMPACT ANALYSIS TRAINING PROGRAM SCHEDULED FOR NOVEMBER 2016

Published Jul 18, 2016
Two-Day BIA Training to be Held in Durham, NC, USA  Princeton, NJ—July 18, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today that it will be holding a two-day training program on budget impact analysis, Building a Budget Impact Model: Budget Impact Analysis Training, in Durham, NC, USA on November 16-17, 2016. Health care treatments are increasingly assessed by reimbursement authorities to determine the impact a therapy may have on the health system’s budget. As a result, budget impact analyses (BIAs) now play an essential role in the evaluation of therapeutic options, and understanding of BIA is vital knowledge for professionals and administrators working in health care today. The ISPOR BIA training program is designed for anyone who develops, utilizes, or funds/sponsors BIA models. The two-day course will be taught by preeminent thought leaders in the field that includes: Additional information on the ISPOR BIA training program can be found here. ###

Related Stories

Landmark Analysis in Value in Health Uncovers Potential Research Efficiency Gains

Sep 15, 2025

Value in Health, the official journal of ISPOR announced the publication of a landmark scoping review that provides a comprehensive mapping of patient preference studies across key medical domains, revealing the first robust evidence base for advancing meta-analyses and benefit transfer methods in healthcare decision-making.

ISPOR Real-World Evidence Summit 28-30 September 2025 | Tokyo, Japan

Sep 9, 2025

ISPOR announced details for its ISPOR Real-World Evidence Summit 2025: Through The Lens of Asia Pacific. The Summit brings together top experts, decision makers, and industry leaders to explore the latest breakthroughs, share cutting-edge research, and discuss innovative solutions to the region’s most pressing healthcare challenges.

"Most-Favored Nation" Drug Pricing Strategy May Backfire, New Research Warns

Sep 3, 2025

Value in Health, the official journal of ISPOR announced the publication of a new analysis suggesting that the Trump Administration's "Most-Favored Nation" approach to lowering US drug prices by referencing international prices may not achieve its intended goals, based on decades of experience with similar policies in Europe.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×